[1] 田思雨, 王志勇, 娄青林, 等. 南京市城区老年人群2000年和2017年糖尿病自我报告患病率情况及变化[J]. 实用老年医学, 2023, 37(6):615-619. [2] 中国老年2型糖尿病防治临床指南编写组, 中国老年医学学会老年内分泌代谢分会, 中国老年保健医学研究会老年内分泌与代谢分会, 等. 中国老年2型糖尿病防治临床指南(2022年版)[J]. 中华内科杂志, 2022, 61(1):12-50. [3] FROYEN E. The effects of fat consumption on low-density lipoprotein particle size in healthy individuals: a narrative review[J]. Lipids Health Dis, 2021, 20(1):86. [4] AI M, OTOKOZAWA S, ASZTALOS B F, et al. Small dense LDL cholesterol and coronary heart disease: results from the Framingham Offspring Study[J]. Clin Chem, 2010, 56(6):967-976. [5] WU D, YANG Q, SU B, et al. Low-density lipoprotein cholesterol 4: the notable risk factor of coronary artery disease development[J]. Front Cardiovasc Med, 2021, 8:619386. [6] PARK S E, PARK C Y, SWEENEY G. Biomarkers of insulin sensitivity and insulin resistance: past, present and future[J]. Crit Rev Clin Lab Sci, 2015, 52(4):180-190. [7] TAHAPARY D L, PRATISTHITA L B, FITRI N A, et al. Challenges in the diagnosis of insulin resistance: focusing on the role of HOMA-IR and tryglyceride/glucose index[J]. Diabetes Metab Syndr, 2022, 16(8):102581. [8] SELVI N M K, NANDHINI S, SAKTHIVADIVEL V, et al. Association of triglyceride-glucose index (TyG index) with HbA1c and insulin resistance in type 2 diabetes mellitus[J]. Maedica: Bucur, 2021, 16(3):375-381. [9] SUPERKO H, GARRETT B. Small dense LDL: scientific background, clinical relevance, and recent evidence still a risk even with ‘normal’ LDL-C Levels[J]. Biomedicines, 2022, 10(4):829. [10] JIN X, YANG S, LU J, et al. Small, dense low-density lipoprotein-cholesterol and atherosclerosis: relationship and therapeutic strategies[J]. Front Cardiovasc Med, 2021, 8:804214. [11] RIKHI R, SCHAICH C L, HAFZALLA G W, et al. Small dense low-density lipoprotein cholesterol and coronary artery calcification in the multi-ethnic study of atherosclerosis[J]. Eur J Prev Cardiol, 2024, 31(8):1048-1054. [12] SCHAEFER E J, IKEZAKI H, DIFFENDERFER M R, et al. Atherosclerotic cardiovascular disease risk and small dense low-density lipoprotein cholesterol in men, women, African Americans and non-African Americans: the pooling project[J]. Atherosclerosis, 2023, 367:15-23. [13] HUANG J, GU J X, BAO H Z, et al. Elevated serum small dense low-density lipoprotein cholesterol may increase the risk and severity of coronary heart disease and predict cardiovascular events in patients with type 2 diabetes mellitus[J]. Dis Markers, 2021, 2021:5597028. [14] TAO L C, XU J N, WANG T T, et al. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations[J]. Cardiovasc Diabetol, 2022, 21(1):68. [15] MORA S, OTVOS J D, ROSENSON R S, et al. Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women[J]. Diabetes, 2010, 59(5):1153-1160. [16] WEI D, MARRACHELLI V G, MELGAREJO J D, et al. Lipoprotein profiles of fat distribution and its association with insulin sensitivity[J]. Front Endocrinol: Lausanne, 2022, 13:978745. [17] KIM S, LEE J W, LEE Y, et al. Association between triglyceride-glucose index and low-density lipoprotein particle size in Korean obese adults[J]. Lipids Health Dis, 2023, 22(1):94. [18] RASHID S, WATANABE T, SAKAUE T, et al. Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity[J]. Clin Biochem, 2003, 36(6):421-429. [19] PONT F, DUVILLARD L, FLORENTIN E, et al. Early kinetic abnormalities of apoB-containing lipoproteins in insulin-resistant women with abdominal obesity[J]. Arterioscler Thromb Vasc Biol, 2002, 22(10):1726-1732. [20] VERGES B. Pathophysiology of diabetic dyslipidaemia: where are we?[J]. Diabetologia, 2015, 58(5):886-899. |